UK markets open in 2 hours 45 minutes

OSE Immunotherapeutics SA (0RAD.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
5.02+5.02 (-19.71%)
At close: 06:51PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.10
52-week change 3N/A
S&P500 52-week change 3-10.89%
52-week high 30.00
52-week low 30.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 514.61M
Implied shares outstanding 6N/A
Float 811.5M
% held by insiders 139.03%
% held by institutions 11.79%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022


Profit margin -21.99%
Operating margin (ttm)-25.38%

Management effectiveness

Return on assets (ttm)-5.28%
Return on equity (ttm)-14.81%

Income statement

Revenue (ttm)33.38M
Revenue per share (ttm)1.81
Quarterly revenue growth (yoy)78.80%
Gross profit (ttm)26.31M
Net income avi to common (ttm)-7.34M
Diluted EPS (ttm)-0.93
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)31.19M
Total cash per share (mrq)1.68
Total debt (mrq)35.77M
Total debt/equity (mrq)76.44
Current ratio (mrq)2.17
Book value per share (mrq)2.53

Cash flow statement

Operating cash flow (ttm)-5.24M
Levered free cash flow (ttm)-2.87M